JAMDA
Volume 7, Issue 9, Supplement , Pages S13-S16 , November 2006

Implications of Medicare Part D in CKD Anemia Treatment

  • Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, University of the Sciences, 600 South 43rd Street, Philadelphia, PA 19104.

References 

  1. Centers for Medicare & Medicaid Services. Medicare and you handbook: 2006. Available at: www.medicare.gov/Publications/Search/Results.asp?PubID=10050&Type=PubID&Language=English. Accessed September 29, 2006.
  2. Biles B, Dallek G, Nicholas LH. Medicare advantage: deja vu all over again? Health Aff (Millwood). 2004;(Suppl Web Exclusives):W4-586-97.
  3. Stefanacci RG. Medicare reform’s impact on long-term care. J Am Med Dir Assoc. 2004;5:418–421
  4. http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1530. Accessed May 16, 2006.
  5. Stefanacci RG. Are you health insurance literate? A question for physicians. J Am Geriatr Soc. 2005;54:166–168
  6. Stuart B, Simoni-Wastila L, Baysac F, et al. Coverage and use of prescription drugs in nursing homes: implications for the Medicare Modernization Act. Med Care. 2006;44:243–249
  7. http://www.statehealthfacts.org Accessed March 28, 2006.
  8. Stefanacci RG. Ten most asked questions about the Medicare prescription drug program. Clin Geriatr. 2005;13:9–12
  9. http://www.bcbsla.com/web/medicare_part_d/MedicarePartD2_Welcome.asp. Accessed May 16, 2006.
  10. http://www.medicalnewstoday.com/medicalnews.php?newsid=41724. Accessed May 16, 2006.
  11. United States Pharmacopeia. Model Guidelines Version 2.0 Tracked Revisions. Available at: www.usp.org/pdf/EN/mmg/modelGuidelinesV2.0TrackedChanges-2006-02-06.pdf. Accessed September 29, 2006.

PII: S1525-8610(06)00459-2

doi: 10.1016/j.jamda.2006.09.006

JAMDA
Volume 7, Issue 9, Supplement , Pages S13-S16 , November 2006

Article Tools

* Image Usage & Resolution